IShares Healthcare Financial Statements From 2010 to 2025
| IHF Etf | USD 52.07 1.13 2.22% |
Check IShares Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IShares Healthcare's main balance sheet or income statement drivers, such as , as well as many indicators such as . IShares financial statements analysis is a perfect complement when working with IShares Healthcare Valuation or Volatility modules.
IShares |
iShares Healthcare Providers ETF Price To Sales Analysis
IShares Healthcare's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current IShares Healthcare Price To Sales | 0.53 X |
Most of IShares Healthcare's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, iShares Healthcare Providers is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
IShares Healthcare Price To Sales Component Assessment
Based on the latest financial disclosure, iShares Healthcare Providers has a Price To Sales of 0.53 times. This is 82.76% higher than that of the iShares family and 79.96% lower than that of the Health category. The price to sales for all United States etfs is 60.61% lower than that of the firm.
iShares Healthcare Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IShares Healthcare's current stock value. Our valuation model uses many indicators to compare IShares Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IShares Healthcare competition to find correlations between indicators driving IShares Healthcare's intrinsic value. More Info.iShares Healthcare Providers is rated fifth overall ETF in price to earning as compared to similar ETFs. It also is rated fifth overall ETF in price to book as compared to similar ETFs fabricating about 0.11 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for iShares Healthcare Providers is roughly 9.37 . Comparative valuation analysis is a catch-all technique that is used if you cannot value IShares Healthcare by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About IShares Healthcare Financial Statements
IShares Healthcare stakeholders use historical fundamental indicators, such as IShares Healthcare's revenue or net income, to determine how well the company is positioned to perform in the future. Although IShares Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in IShares Healthcare's assets and liabilities are reflected in the revenues and expenses on IShares Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in iShares Healthcare Providers. Please read more on our technical analysis and fundamental analysis pages.
The index measures the performance of the healthcare providers sector of the U.S. equity market, as defined by SPDJI. US Healthcare is traded on NYSEARCA Exchange in the United States.
Currently Active Assets on Macroaxis
When determining whether iShares Healthcare is a strong investment it is important to analyze IShares Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact IShares Healthcare's future performance. For an informed investment choice regarding IShares Etf, refer to the following important reports:Check out the analysis of IShares Healthcare Correlation against competitors. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
The market value of iShares Healthcare is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Healthcare's value that differs from its market value or its book value, called intrinsic value, which is IShares Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Healthcare's market value can be influenced by many factors that don't directly affect IShares Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.